8-K: Village Farms International Reports Record Q2 Sales, Canadian Cannabis Business Surges

Village Farms International announced a 19% year-over-year increase in total sales to $92.1 million for the second quarter of 2024, driven by strong growth in its Canadian cannabis segment.

Summary

• Village Farms International reported a 19% increase in total sales to $92.1 million in the second quarter of 2024, compared to $77.2 million in the same period last year.
• The company's Canadian cannabis business saw a 45% increase in net sales, reaching $40.7 million, with retail branded sales growing by 35%.
• The Canadian cannabis segment also achieved positive adjusted EBITDA and operating cash flow for the quarter.
• Fresh produce sales grew by 7% year-over-year to $47.1 million, with an improved gross loss for the first half of 2024.
• The company reported a consolidated net loss of $23.5 million, or $0.21 per share, which includes a $11.9 million goodwill and intangible asset impairment related to U.S. cannabis.
• Adjusted consolidated EBITDA was a loss of $3.6 million, compared to a profit of $4.5 million in the prior year.
• Consolidated cash flow from operations improved to $5.7 million from a cash outflow of $1.6 million in the same quarter last year.

Sentiment

Score: 5

Explanation: The document presents mixed results. While the Canadian cannabis business shows strong growth, the overall financial performance is negatively impacted by losses in the U.S. cannabis and fresh produce segments. The impairment charge also weighs on the sentiment.

Positives

• The Canadian cannabis business is showing strong growth with significant increases in sales and market share.
• The company is making progress in reducing non-brand-spec inventory, which is expected to improve cash flow.
• The fresh produce business is showing improved gross loss year-to-date due to cost management and efficiency initiatives.
• The company is expanding its third-party supply in fresh produce to support long-term growth.
• The company has extended its credit agreement, providing additional financial flexibility.
• The Delta, British Columbia Renewable Natural Gas Project has commenced operations, contributing to incremental profit.
• The company increased its ownership of Rose LifeScience to 80%, which is immediately accretive to adjusted EBITDA and net income.

Negatives

• The company reported a consolidated net loss of $23.5 million, which includes a $11.9 million impairment related to U.S. cannabis.
• Consolidated adjusted EBITDA was a loss of $3.6 million, down from a profit of $4.5 million in the same quarter last year.
• The U.S. cannabis business experienced a net loss of $12.3 million.
• The fresh produce business reported a net loss of $8.3 million.
• Gross margin in the Canadian cannabis segment decreased to 26% from 38% due to sales of non-brand-spec inventory.

Risks

• The company faces risks related to the legal status of cannabis in the United States.
• There are risks associated with integrating Balanced Health and Rose into the consolidated business.
• The company is dependent on credit facilities and dilutive transactions for financing.
• The company faces potential difficulties in achieving and maintaining profitability.
• There is variability in product pricing in the cannabis and produce markets.
• The company is vulnerable to rising energy costs and inflationary effects on costs of cultivation and transportation.
• The company faces risks related to regulatory compliance and obtaining and maintaining licenses.
• The company is exposed to foreign exchange risks and risks associated with cross-border trade.

Future Outlook

The company expects continued growth in its Canadian cannabis business and improved performance in its fresh produce business in the third and fourth quarters of 2024. Production in the Netherlands is expected to start in a few months with first sales in the first quarter of next year.

Management Comments

• Michael DeGiglio, President and Chief Executive Officer, stated that they are driving strong momentum in their Canadian Cannabis business and are closing in on the number one market share position nationally.
• Management noted that they are taking advantage of a favorable wholesale market to reduce non-brand-spec inventory.
• Management expects production to start in the Netherlands in a few months with first sales in the first quarter of next year.
• Management expects continued yield-focused initiatives, cost improvements and the current recovery in market pricing should generate significantly improved performance in both the third and fourth quarters of this year in the Fresh Produce business.

Industry Context

The company's performance reflects the ongoing growth and competition in the Canadian cannabis market, where Village Farms is aiming to become the number one player. The company is also expanding its international presence in the cannabis market. The fresh produce business is facing market pricing pressures but is implementing cost management and efficiency initiatives to improve performance.

Comparison to Industry Standards

• Village Farms' Canadian cannabis business is outperforming many of its peers, being the only top-five producer to grow market share sequentially.
• The company's focus on branded retail sales in the Canadian cannabis market aligns with industry trends towards higher-margin products.
• The company's expansion into the Netherlands cannabis market is a strategic move to capitalize on emerging international opportunities, similar to other large cannabis producers.
• The company's fresh produce business is facing similar challenges to other greenhouse operators, including market pricing pressures and the need for cost efficiencies.
• The impairment in the U.S. cannabis business reflects the challenges faced by many companies in the CBD market due to regulatory uncertainty and market saturation.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders will be concerned about the net loss and the impairment charge.
• Employees in the Canadian cannabis segment may be encouraged by the strong growth and market share gains.
• Employees in the U.S. cannabis and fresh produce segments may be concerned about the losses in those areas.
• Customers of the Canadian cannabis business will likely benefit from the company's focus on product innovation and market share growth.
• Suppliers may see increased opportunities as the company expands its operations.

Next Steps

• The company plans to continue the build-out of its cannabis production facility in the Netherlands, with production expected to begin in the fourth quarter of 2024.
• The company will continue to implement cost management and efficiency initiatives in its fresh produce business.
• The company will continue to evaluate other uses for its Monahans greenhouse facility.
• The company will continue to pursue a Texas medicinal marijuana license.

Key Dates

Keywords

cannabis, fresh produce, financial results, sales growth, EBITDA, market share, greenhouse, Pure Sunfarms, Rose LifeScience, CBD, Balanced Health Botanicals